We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Indivior Wins Bid To Block Sales Of Suboxone Generic

Law360 (July 13, 2018, 11:54 PM EDT) -- Determining that drugmaker Indivior will likely be able to show its suit claiming infringement by Dr. Reddy’s of a so-called child patent covering its Suboxone Film will not be precluded by a suit in which Dr. Reddy’s was cleared of infringement of the parent patent, a New Jersey federal judge on Friday granted Indivior a preliminary injunction blocking sales.

Indivior previously lost a series of Delaware federal court cases in which it attempted to show that Dr. Reddy’s generic version of the opiate addiction treatment Suboxone...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

INDIVIOR INC. et al v. DR. REDDY'S LABORATORIES S.A. et al


Case Number

2:17-cv-07111

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Judge

Kevin McNulty

Date Filed

September 14, 2017


Case Title

INDIVIOR INC. et al v. DR. REDDY'S LABORATORIES, S.A. et al


Case Number

2:18-cv-01775

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Judge

Kevin McNulty

Date Filed

February 7, 2018


Case Title

INDIVIOR INC. et al v. DR. REDDY'S LABORATORIES, INC. et al


Case Number

2:18-cv-05288

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Judge

Kevin McNulty

Date Filed

April 3, 2018

Law Firms

Companies

Government Agencies

Patents

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.